What Makes a Medtech Company Investable? Interview with Neuros Medical CEO David Veino episode artwork

EPISODE · Aug 4, 2026 · 52 MIN

What Makes a Medtech Company Investable? Interview with Neuros Medical CEO David Veino

from Medsider: Learn from Medtech and Healthtech Founders and CEOs · host Scott Nelson

In this episode, we sat down with David Veino ( https://www.linkedin.com/in/david-veino-a452158/ ), President and CEO of Neuros Medical ( https://www.neurosmedical.com/ ). Neuros is commercializing the FDA-approved Altius Direct Electrical Nerve Stimul...

Episode metadata supplied by the publisher feed · Published Aug 4, 2026

Embed this episode

Ready to play

What Makes a Medtech Company Investable? Interview with Neuros Medical CEO David Veino

0:00 52:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medsider: Learn from Medtech and Healthtech Founders and CEOs?

This episode is 52 minutes long.

When was this Medsider: Learn from Medtech and Healthtech Founders and CEOs episode published?

This episode was published on August 4, 2026.

Can I download this Medsider: Learn from Medtech and Healthtech Founders and CEOs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!